Nicholson, C. David
Insider CIK 1636168 · ATNM Director · ADVM Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2026-09-02 | 2026-09-04 | 94,200 | — | $0 | 94,200 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award | 2026-09-02 | 2026-09-04 | 62,800 | — | $0 | 63,300 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2026-09-02 | 2026-09-04 | 94,200 | — | $0 | 94,200 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award | 2026-09-02 | 2026-09-04 | 62,800 | — | $0 | 63,300 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,450 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 10,520 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 8,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2025-06-17 | 2025-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 2,500 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 2,500 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 2,500 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 8,333 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 8,333 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 18,351 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 70,311 | — | $0 | 0 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer deriv | 2025-03-31 | 2025-04-02 | 72,156 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2024-06-17 | 2024-06-20 | 10,520 | — | $0 | 10,520 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2023-12-28 | 2023-12-29 | 70,311 | — | $0 | 70,311 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2023-11-03 | 2023-11-06 | 80,000 | — | $0 | 80,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2022-07-01 | 2022-07-01 | 72,156 | — | $0 | 72,156 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2021-09-01 | 2021-09-03 | 18,351 | — | $0 | 18,351 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2020-08-12 | 2020-08-14 | 8,333 | — | $0 | 8,333 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2019-07-12 | 2019-07-16 | 250,000 | $0.23 | $57.5K | 250,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2018-07-13 | 2018-07-17 | 75,000 | $0.78 | $58.5K | 75,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2017-03-14 | 2017-03-16 | 75,000 | $1.39 | $104.2K | 75,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2016-04-15 | 2016-04-18 | 75,000 | $1.99 | $149.3K | 75,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | P Buy | 2016-04-14 | 2016-04-18 | 5,000 | $2.00 | $10.0K | 15,000 | SEC↗ |